We recently compiled a list of the 10 Best Russell 2000 Stocks to Invest in According to Analysts. In this article, we are ...

The Microbiomes Market is experiencing significant growth due to the increasing research and development in the field of ...

Using a novel approach accounting for prescriber preference, researchers found that longer durations of antibiotic therapy ...

Among 547 episodes of C difficile infection documented in cancer patients in Australia and Spain, 50% were severe, and the 90 ...

Highlights:New Research Collaboration with Monash University One proposal will target Antimicrobial Resistant Pathways to develop broad spectrum ...

In a small randomized trial, people who took capsules containing donated gut microbiomes experienced fewer gastrointestinal ...

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that it has submitted the Clinical Study Report to the U.S. Food ...

The panelist discusses how recurrent Clostridioides difficile infection significantly increases health care costs through prolonged hospitalizations, complex treatments, and elevated medical resource ...

Nosocomial Clostridioides difficile infections were linked to higher mortality, longer hospital stays, and increased ...

RSV, norovirus, and the flu are all on the rise again and contrary to popular belief, hand sanitizer may not work to kill all of those germs.  According to the Centers ...

A newly published study from Aarhus University Hospital shows that fecal microbiota transplantation (FMT)—a method where gut ...

NDAQ:ACXP) Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...